Elisavet Efstathiou

444 total citations
20 papers, 231 citations indexed

About

Elisavet Efstathiou is a scholar working on Genetics, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Elisavet Efstathiou has authored 20 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Elisavet Efstathiou's work include Sexual Differentiation and Disorders (5 papers), Hormonal and reproductive studies (4 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (4 papers). Elisavet Efstathiou is often cited by papers focused on Sexual Differentiation and Disorders (5 papers), Hormonal and reproductive studies (4 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (4 papers). Elisavet Efstathiou collaborates with scholars based in Cyprus, Greece and United States. Elisavet Efstathiou's co-authors include Nicos Skordis, Leonidas A. Phylactou, Vassos Neocleous, Adamos Hadjipanayis, Christos Shammas, Andreas Kyriakou, Savvas C. Savva, Vasiliki Papaevangelou, David Neubauer and Meropi Toumba and has published in prestigious journals such as PLoS ONE, Gene and Vaccine.

In The Last Decade

Elisavet Efstathiou

20 papers receiving 229 citations

Peers

Elisavet Efstathiou
Yannis K. Valtis United States
Maurice Katz South Africa
Ailsa Gebbie United Kingdom
Lisa Robson Australia
Bülent Urman Türkiye
Elisavet Efstathiou
Citations per year, relative to Elisavet Efstathiou Elisavet Efstathiou (= 1×) peers Daniela Visconti

Countries citing papers authored by Elisavet Efstathiou

Since Specialization
Citations

This map shows the geographic impact of Elisavet Efstathiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisavet Efstathiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisavet Efstathiou more than expected).

Fields of papers citing papers by Elisavet Efstathiou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisavet Efstathiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisavet Efstathiou. The network helps show where Elisavet Efstathiou may publish in the future.

Co-authorship network of co-authors of Elisavet Efstathiou

This figure shows the co-authorship network connecting the top 25 collaborators of Elisavet Efstathiou. A scholar is included among the top collaborators of Elisavet Efstathiou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisavet Efstathiou. Elisavet Efstathiou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Theodosiou, Athina, et al.. (2020). First reported case of Steel syndrome in the European population: A novel homozygous mutation in COL27A1 and review of the literature. European Journal of Medical Genetics. 63(7). 103939–103939. 8 indexed citations
2.
Efstathiou, Elisavet. (2020). The child healthcare system in Cyprus. Türk Pediatri Arşivi. 55(Suppl 1). 24–40. 6 indexed citations
3.
Hadjipanayis, Adamos, Elisavet Efstathiou, Tom Stiris, et al.. (2019). Social media and children: what is the paediatrician’s role?. European Journal of Pediatrics. 178(10). 1605–1612. 17 indexed citations
4.
Hadjipanayis, Adamos, Elisavet Efstathiou, & Vasiliki Papaevangelou. (2019). Hepatotoxicity in an Adolescent with Black Iced Tea Overconsumption. Pediatric Gastroenterology Hepatology & Nutrition. 22(4). 387–387. 2 indexed citations
5.
Fanis, Pavlos, Elisavet Efstathiou, Vassos Neocleous, Leonidas A. Phylactou, & Adamos Hadjipanayis. (2019). A novel heterozygous duplication of the SLC12A3 gene in two Gitelman syndrome pedigrees: indicating a founder effect. Journal of Genetics. 98(1). 3 indexed citations
7.
Hadjipanayis, Adamos, et al.. (2017). Reversible brain lesion following growth hormone replacement therapy in an adolescent. BMJ Case Reports. 2017. bcr–2017. 1 indexed citations
8.
Hadjipanayis, Adamos, et al.. (2016). Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines. PLoS ONE. 11(10). e0163269–e0163269. 22 indexed citations
9.
Efstathiou, Elisavet, et al.. (2016). Rapid Onset of Purpuric Rash in an Otherwise Healthy 6-Month-Old Infant. Clinical Pediatrics. 56(14). 1377–1380. 1 indexed citations
10.
Hadjipanayis, Adamos, Elisavet Efstathiou, & David Neubauer. (2015). Benign paroxysmal torticollis of infancy: An underdiagnosed condition. Journal of Paediatrics and Child Health. 51(7). 674–678. 15 indexed citations
11.
Shammas, Christos, Vassos Neocleous, Meropi Toumba, et al.. (2012). Overview of Genetic Defects in Endocrinopathies in the Island of Cyprus; Evidence of a Founder Effect. Genetic Testing and Molecular Biomarkers. 16(9). 1073–1079. 14 indexed citations
12.
Neocleous, Vassos, Carolina Sismani, Christos Shammas, et al.. (2012). Duplication of exons 3–10 of the HSD17B3 gene: A novel type of genetic defect underlying 17β-HSD-3 deficiency. Gene. 499(2). 250–255. 12 indexed citations
13.
Skordis, Nicos, Elisavet Efstathiou, Tassos C. Kyriakides, et al.. (2012). Epidemiology of Type 1 diabetes mellitus in Cyprus: rising incidence at the dawn of the 21st century. HORMONES. 11(1). 86–93. 17 indexed citations
14.
Neocleous, Vassos, Nicos Skordis, Christos Shammas, et al.. (2012). Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: A case report and review of the literature. Metabolism. 61(7). 922–930. 23 indexed citations
15.
Skordis, Nicos, et al.. (2011). Endocrine profile and phenotype-genotype correlation in unrelated patients with non-classical congenital adrenal hyperplasia. Clinical Biochemistry. 44(12). 959–963. 16 indexed citations
16.
Skordis, Nicos, Christos Shammas, Elisavet Efstathiou, et al.. (2011). Late diagnosis of 5alpha steroid-reductase deficiency due to IVS12A>G mutation of the SRD5a2 gene in an adolescent girl presented with primary amenorrhea. HORMONES. 10(3). 230–235. 5 indexed citations
17.
Neocleous, Vassos, Nicos Skordis, Elisavet Efstathiou, et al.. (2011). RET proto-oncogene mutations are restricted to codon 618 in Cypriot families with multiple endocrine neoplasia 2.. PubMed. 34(10). 764–9. 6 indexed citations
18.
Skordis, Nicos, Vassos Neocleous, Andreas Kyriakou, et al.. (2010). The IVS1- 2A>G mutation in the SRD5A2 gene predominates in Cypriot patients with 5α reductase deficiency. Journal of Endocrinological Investigation. 33(11). 810–814. 16 indexed citations
19.
Skordis, Nicos, et al.. (2008). Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.. PubMed. 6 Suppl 1. 144–8. 24 indexed citations
20.
Skordis, Nicos, Elisavet Efstathiou, Andreas Kyriakou, & Meropi Toumba. (2008). Hormonal dysregulation and bones in thalassaemia--an overview.. PubMed. 6 Suppl 1. 107–15. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026